| CID 53358901 | IC50 | 35.0 [1] |
| 2-[4-(3-Chlorophenyl)phenyl]-5-[3-(1,8-naphthyridin-2-yl)propyl]-1,3,4-oxadiazole | IC50 | 40.0 [1] |
| Hgpr91 antagonist 1 | IC50 | 7.0 [1] |
| N-[[4-(3-Methylphenyl)phenyl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 30.0 [1] |
| Methyl 2-fluoro-6-[3-fluoro-4-[[4-(1,8-naphthyridin-2-yl)butanoylamino]methyl]phenyl]benzoate | IC50 | 800.0 [1] |
| N-[[4-(3-Methoxyphenyl)phenyl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 1000.0 [1] |
| 2,2-Difluoro-N-[(1S)-1-[4-[4-fluoro-3-(trifluoromethyl)phenyl]phenyl]ethyl]-2-[4-(1,8-naphthyridin-2-yl)phenyl]acetamide | IC50 | 19.0 [1] |
| N-[[3-(3-Chlorophenyl)-1,2-oxazol-5-yl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 65.0 [1] |
| N-[[5-[4-Fluoro-3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 1000.0 [1] |
| 2-[4-(3-Chlorophenyl)phenyl]-5-[3-(1,8-naphthyridin-2-yl)propyl]-1,3,4-thiadiazole | IC50 | 3000.0 [1] |
| 2-[3-Chloro-4-(trifluoromethoxy)phenyl]-5-[4-(1,8-naphthyridin-2-yl)butyl]-1,3,4-oxadiazole | IC50 | 180.0 [1] |
| 2-[4-Fluoro-3-(trifluoromethyl)phenyl]-5-[4-(1,8-naphthyridin-2-yl)butyl]-1,3,4-oxadiazole | IC50 | 2000.0 [1] |
| N-[[4-[4-Fluoro-3-(trifluoromethyl)phenyl]phenyl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 22.0 [1] |
| N-[[2-Fluoro-4-[3-(trifluoromethyl)phenyl]phenyl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 41.0 [1] |
| N-[[5-[4-Fluoro-3-(trifluoromethyl)phenyl]pyrimidin-2-yl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 200.0 [1] |
| 2-[4-(1,8-Naphthyridin-2-yl)butyl]-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazole | IC50 | 3000.0 [1] |
| 2-(4-Chlorophenyl)-5-[4-(1,8-naphthyridin-2-yl)butyl]-1,3,4-oxadiazole | IC50 | 3000.0 [1] |
| 2-[4-Chloro-3-(trifluoromethyl)phenyl]-5-[4-(1,8-naphthyridin-2-yl)butyl]-1,3,4-oxadiazole | IC50 | 160.0 [1] |
| 4-(1,8-Naphthyridin-2-yl)-N-[1-[4-[3-(trifluoromethyl)phenyl]phenyl]ethyl]butanamide | IC50 | 16.0 [1] |
| N-[(1S)-1-[4-[4-Fluoro-3-(trifluoromethyl)phenyl]phenyl]ethyl]-2-methyl-2-[4-(1,8-naphthyridin-2-yl)phenyl]propanamide | IC50 | 14.0 [1] |
| N-[[6-[4-Fluoro-3-(trifluoromethyl)phenyl]pyridazin-3-yl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 720.0 [1] |
| N-[[3-(3-Chloro-4-fluorophenyl)-1,2-oxazol-5-yl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 90.0 [1] |
| N-[[4-(3-Chlorophenyl)-1,3-thiazol-2-yl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 300.0 [1] |
| N-[[4-(3-Ethylphenyl)phenyl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 65.0 [1] |
| 4-(1,8-Naphthyridin-2-yl)-N-[[4-[3-(trifluoromethoxy)phenyl]phenyl]methyl]butanamide | IC50 | 500.0 [1] |
| N-[[2-(3-Chlorophenyl)-1,3-thiazol-4-yl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 700.0 [1] |
| 2-[4-(3-Chloro-4-fluorophenyl)phenyl]-5-[3-(1,8-naphthyridin-2-yl)propyl]-1,3,4-oxadiazole | IC50 | 100.0 [1] |
| 2-[4-(1,8-Naphthyridin-2-yl)butyl]-5-[4-(trifluoromethoxy)phenyl]-1,3,4-oxadiazole | IC50 | 3000.0 [1] |
| N-[[4-(4-Chloro-3-methylphenyl)phenyl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 300.0 [1] |
| N-[[4-(3-Chloro-4-fluorophenyl)phenyl]methyl]-2-[4-(1,8-naphthyridin-2-yl)phenyl]acetamide | IC50 | 31.0 [1] |
| 3,3,3-Trifluoro-N-[[4-[4-fluoro-3-(trifluoromethyl)phenyl]phenyl]methyl]-2-hydroxy-2-[4-(1,8-naphthyridin-2-yl)phenyl]propanamide | IC50 | 34.0 [1] |
| 2-Amino-N-[[4-[4-fluoro-3-(trifluoromethyl)phenyl]phenyl]methyl]-2-[4-(1,8-naphthyridin-2-yl)phenyl]acetamide | IC50 | 330.0 [1] |
| 2-[3,4-Bis(trifluoromethyl)phenyl]-5-[4-(1,8-naphthyridin-2-yl)butyl]-1,3,4-oxadiazole | IC50 | 170.0 [1] |
| 2-[4-Fluoro-3-(trifluoromethoxy)phenyl]-5-[4-(1,8-naphthyridin-2-yl)butyl]-1,3,4-oxadiazole | IC50 | 4000.0 [1] |
| N-[[4-[4-Fluoro-3-(trifluoromethyl)phenyl]phenyl]methyl]-2-methyl-2-[4-(1,8-naphthyridin-2-yl)phenyl]propanamide | IC50 | 17.0 [1] |
| N-[[5-[4-Fluoro-3-(trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-yl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 270.0 [1] |
| 2-[3-(1,8-Naphthyridin-2-yl)propyl]-5-[4-[3-(trifluoromethyl)phenyl]phenyl]-1,3,4-oxadiazole | IC50 | 200.0 [1] |
| 2-[3-[3-[4-(3-Chloro-4-fluorophenyl)phenyl]-1H-1,2,4-triazol-5-yl]propyl]-1,8-naphthyridine | IC50 | 1000.0 [1] |
| 4-(1,8-Naphthyridin-2-yl)-N-[(4-phenylphenyl)methyl]butanamide | IC50 | 1000.0 [1] |
| N-[(1S)-1-[4-(3-Chlorophenyl)phenyl]ethyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 11.0 [1] |
| 3,3,3-Trifluoro-N-[(1S)-1-[4-[4-fluoro-3-(trifluoromethyl)phenyl]phenyl]ethyl]-2-hydroxy-2-[4-(1,8-naphthyridin-2-yl)phenyl]propanamide | IC50 | 16.0 [1] |
| N-[[4-(3-Chlorophenyl)phenyl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 40.0 [1] |
| N-[[4-(3-Chloro-4-fluorophenyl)phenyl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 38.0 [1] |
| N-[[4-[4-Fluoro-3-(trifluoromethyl)phenyl]phenyl]methyl]-2-[4-(1,8-naphthyridin-2-yl)phenyl]acetamide | IC50 | 75.0 [1] |
| N-[(1S)-1-[4-[4-Fluoro-3-(trifluoromethyl)phenyl]phenyl]ethyl]-2-hydroxy-2-[4-(1,8-naphthyridin-2-yl)phenyl]acetamide | IC50 | 18.0 [1] |
| N-[[2-[4-Fluoro-3-(trifluoromethyl)phenyl]pyrimidin-5-yl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 49.0 [1] |
| N-[[1-[4-Fluoro-3-(trifluoromethyl)phenyl]pyrazol-4-yl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide | IC50 | 210.0 [1] |